120 related articles for article (PubMed ID: 19014473)
1. Competing risks to breast cancer mortality in Catalonia.
Vilaprinyo E; Gispert R; Martínez-Alonso M; Carles M; Pla R; Espinàs JA; Rué M
BMC Cancer; 2008 Nov; 8():331. PubMed ID: 19014473
[TBL] [Abstract][Full Text] [Related]
2. Competing risks to breast cancer mortality.
Rosenberg MA
J Natl Cancer Inst Monogr; 2006; (36):15-9. PubMed ID: 17032889
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of early detection on breast cancer mortality reduction in Catalonia (Spain).
Rue M; Vilaprinyo E; Lee S; Martinez-Alonso M; Carles MD; Marcos-Gragera R; Pla R; Espinas JA
BMC Cancer; 2009 Sep; 9():326. PubMed ID: 19754959
[TBL] [Abstract][Full Text] [Related]
4. Contribution of Breast Cancer to Overall Mortality for US Women.
Gangnon RE; Stout NK; Alagoz O; Hampton JM; Sprague BL; Trentham-Dietz A
Med Decis Making; 2018 Apr; 38(1_suppl):24S-31S. PubMed ID: 29554467
[TBL] [Abstract][Full Text] [Related]
5. Competing mortality risks among women aged 50-79 years when diagnosed with invasive breast cancer, Queensland, 1997-2012.
Dasgupta P; Aitken JF; Pyke C; Baade PD
Breast; 2018 Oct; 41():113-119. PubMed ID: 30029053
[TBL] [Abstract][Full Text] [Related]
6. [Risk of developing and dying from cancer in Catalonia, Spain].
Moreno V; Sánchez V; Galceran J; Borràs JM; Borràs J; Bosch FX
Med Clin (Barc); 1998 Jan; 110(3):86-93. PubMed ID: 9534139
[TBL] [Abstract][Full Text] [Related]
7. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
He VY; Condon JR; Baade PD; Zhang X; Zhao Y
Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
[TBL] [Abstract][Full Text] [Related]
8. Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain).
Rue M; Carles M; Vilaprinyo E; Martinez-Alonso M; Espinas JA; Pla R; Brugulat P
BMC Cancer; 2008 Nov; 8():336. PubMed ID: 19014679
[TBL] [Abstract][Full Text] [Related]
9. Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona.
Ameijide A; Clèries R; Carulla M; Buxó M; Marcos-Gragera R; Martínez JM; Vilardell ML; Vilardell M; Espinàs JA; Borràs JM; Izquierdo Á; Galceran J
Clin Transl Oncol; 2019 Aug; 21(8):1014-1025. PubMed ID: 30607790
[TBL] [Abstract][Full Text] [Related]
10. Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.
Derks MGM; van de Velde CJH; Giardiello D; Seynaeve C; Putter H; Nortier JWR; Dirix LY; Bastiaannet E; Portielje JEA; Liefers GJ
Oncologist; 2019 Jul; 24(7):e467-e474. PubMed ID: 30606886
[TBL] [Abstract][Full Text] [Related]
11. The lifetime risk of developing breast cancer.
Feuer EJ; Wun LM; Boring CC; Flanders WD; Timmel MJ; Tong T
J Natl Cancer Inst; 1993 Jun; 85(11):892-7. PubMed ID: 8492317
[TBL] [Abstract][Full Text] [Related]
12. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
13. Temporal trends in net and crude probability of death from cancer and other causes in the Australian population, 1984-2013.
Dasgupta P; Cramb S; Kou K; Yu XQ; Baade PD
Cancer Epidemiol; 2019 Oct; 62():101568. PubMed ID: 31330423
[TBL] [Abstract][Full Text] [Related]
14. Estimation of age- and stage-specific Catalan breast cancer survival functions using US and Catalan survival data.
Vilaprinyo E; Rué M; Marcos-Gragera R; Martínez-Alonso M
BMC Cancer; 2009 Mar; 9():98. PubMed ID: 19331670
[TBL] [Abstract][Full Text] [Related]
15. Cohort-specific risks of developing breast cancer to age 85 in Connecticut.
Campbell MK; Feuer EJ; Wun LM
Epidemiology; 1994 May; 5(3):290-6. PubMed ID: 8038242
[TBL] [Abstract][Full Text] [Related]
16. [The risk of breast cancer in Catalonia].
Izquierdo A; Viladiu P; Borrás J; Galcerán J; Borràs JM; Dorca J; Vayreda J; Moreno V
Med Clin (Barc); 1996 Oct; 107(11):410-3. PubMed ID: 9045002
[TBL] [Abstract][Full Text] [Related]
17. Use of risk projection models to estimate mortality and incidence from radiation-induced breast cancer in screening programs.
Ramos M; Ferrer S; Villaescusa JI; Verdú G; Salas MD; Cuevas MD
Phys Med Biol; 2005 Feb; 50(3):505-20. PubMed ID: 15773726
[TBL] [Abstract][Full Text] [Related]
18. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.
Abdel-Qadir H; Austin PC; Lee DS; Amir E; Tu JV; Thavendiranathan P; Fung K; Anderson GM
JAMA Cardiol; 2017 Jan; 2(1):88-93. PubMed ID: 27732702
[TBL] [Abstract][Full Text] [Related]
19. Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain.
Vilaprinyo E; Puig T; Rue M
PLoS One; 2012; 7(1):e30157. PubMed ID: 22272292
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
